| Smith, Angela |
NCT05555589: Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2 |
|
|
| Recruiting | 3 | 70 | US | RGN-259, TĪ²4, Thymosin Beta 4, Timbetasin, Placebo, Vehicle Control | ReGenTree, LLC | Neurotrophic Keratopathy | 07/24 | 11/24 | | |
| Recruiting | 1/2 | 413 | Europe, Canada, US, RoW | revumenib, SNDX-5613, cobicistat | Syndax Pharmaceuticals, Syndax Pharmaceuticals, Inc | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Mixed Lineage Acute Leukemia, Mixed Phenotype Acute Leukemia, Acute Leukemia of Ambiguous Lineage | 12/27 | 12/27 | | |
|
|
|
|
|
|
|
|
|
| Recruiting | 1/2 | 18 | Europe, US | zocaglusagene nuzaparvovec, AT845 | Astellas Gene Therapies | Pompe Disease (Late-onset) | 11/29 | 11/29 | | |
NCT04565431: Examining Effects of Tysabri on Cognitive Fatigue Using fMRI |
|
|
| Recruiting | N/A | 25 | US | Tysabri | Kessler Foundation, St. Barnabas Medical Center | Multiple Sclerosis, Relapsing-Remitting | 12/24 | 12/24 | | |
NCT04448977: Examining Effects of Ocrevus on Cognitive Fatigue Using fMRI |
|
|
| Recruiting | N/A | 60 | US | Ocrevus | Kessler Foundation, Hackensack Meridian Health | Multiple Sclerosis, Relapsing-Remitting | 12/24 | 12/24 | | |
NCT05399004: Evaluating Sexual Function in Women Undergoing a Radical Cystectomy for Bladder Cancer |
|
|
| Completed | N/A | 34 | NA | Survey Administration | Mayo Clinic, National Cancer Institute (NCI) | Bladder Carcinoma | 06/24 | 06/24 | | |
NCT05045794: Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation |
|
|
| Completed | N/A | 219 | US | VitaSmart Liver Machine Perfusion System, VitaSmart Liver Machine, Hypothermic oxygenated perfusion, Static cold storage | Bridge to Life Ltd. | End Stage Liver DIsease, Liver Failure | 06/24 | 06/24 | | |
CISTO, NCT03933826: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer |
|
|
| Active, not recruiting | N/A | 572 | US | | University of Washington, Patient-Centered Outcomes Research Institute | Bladder Cancer, Cancer of the Bladder, Recurrent, Non-muscle Invasive Bladder Cancer | 12/24 | 03/25 | | |
KOAR, NCT03326076: Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry |
|
|
| Active, not recruiting | N/A | 4000 | US | Donor-derived cell-free DNA (AlloSureĀ®), Standard care, Peripheral blood gene expression profiling (AlloMap Kidney), Analytic platform (IBox) | CareDx | Kidney Transplant Rejection | 06/25 | 12/25 | | |
| Mueller, Dana |
NCT03913715: Ostomy Rural Telehealth Training Cancer Survivors |
|
|
| Active, not recruiting | N/A | 204 | US | Ostomy Self-Management Training | University of Pennsylvania, National Cancer Institute (NCI) | Ostomy, Quality of Life, Telehealth | 09/25 | 10/26 | | |
CISTO, NCT03933826: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer |
|
|
| Active, not recruiting | N/A | 572 | US | | University of Washington, Patient-Centered Outcomes Research Institute | Bladder Cancer, Cancer of the Bladder, Recurrent, Non-muscle Invasive Bladder Cancer | 12/24 | 03/25 | | |
